Investigational drug therapies in phase I and phase II clinical trials for alcohol use disorders
Author:
Affiliation:
1. Florey Department of Neuroscience and Mental Health, University of Melbourne, Parkville, VIC, Australia
Funder
National Health and Medical Research Council
Publisher
Informa UK Limited
Subject
Pharmacology (medical),Pharmacology,General Medicine
Link
https://www.tandfonline.com/doi/pdf/10.1080/13543784.2018.1502269
Reference146 articles.
1. Drug Addiction, Dysregulation of Reward, and Allostasis
2. Epidemiology ofDSM-5Alcohol Use Disorder
3. World Health Organization (WHO). Management of Substance Abuse Unit. Global status report on alcohol and health, 2014.
4. Actual Causes of Death in the United States, 2000
5. More Treatments on Deck for Alcohol Use Disorder
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Medication development for AUD: A systematic review of clinical trial methodology;Alcohol;2024-11
2. Aufkommende Suizidgedanken einer bipolaren Patientin nach Einnahme von Pregabalin: ein Fallbericht;Fortschritte der Neurologie · Psychiatrie;2024-08-29
3. Orphan peptide and G protein‐coupled receptor signalling in alcohol use disorder;British Journal of Pharmacology;2024-01-08
4. Targeting muscarinic receptors for the treatment of alcohol use disorders: Opportunities and hurdles for clinical development;British Journal of Pharmacology;2023-05
5. Targeting the Maladaptive Effects of Binge Drinking on Circadian Gene Expression;International Journal of Molecular Sciences;2022-09-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3